Issue · Healthcare

Healthcare (Public Health)

Every healthcare bill, vote, and legislator stance in Washington, automatically classified by Maddy, our AI policy reader.

Total bills
19
2025-2026 Regular Session
Top supporter
Adrian Cortes
67% support rate
Top opponent
-
no data yet
Ranked legislators
4
4 support · 0 oppose
Key legislators

Who's moving public health in Washington

Legislators moving public health in Washington
Legislator Party Stance Support rate Votes
Adrian Cortes
Adrian Cortes Senate · District 18
D
Support
67% 3
Javier Valdez
Javier Valdez Senate · District 46
D
Support
67% 3
Julio Cortes
Julio Cortes House · District 38
D
Support
67% 3
Michelle Valdez
Michelle Valdez House · District 26
R
Support
67% 3
Showing 11–19 of 19 bills

All healthcare bills

in committee · Washington · House Jan 12, 2026

HB 1242: Expanding professional licensing reporting requirements.

HB 1242 requires Washington's Department of Licensing to annually review 10% of state-licensed professions (completing a full review of all licenses within 10 years), producing detailed reports by August 31 each year. These reports must analyze license renewal fees, education/experience requirements, comparisons to other states, and whether regulations are the "least restrictive necessary" to protect public health and safety. The bill directly affects all professional boards and licensees by mandating transparency in licensing costs, renewal timelines, and regulatory justification. The reports will include data on license issuances, revocations, and recommendations for modifying or ending licenses, aiming to streamline oversight without unnecessary barriers.
Sub-Topics Medical Licensing Public Health Tags Licensing
in committee · Washington · Senate Jan 12, 2026

SB 5781: Restoring trust in public health by conforming to food and drug administration labeling.

SB 5781 requires Washington state health departments, agencies, and local health entities to follow U.S. Food and Drug Administration (FDA) labeling rules when promoting or distributing FDA-regulated medical products (like drugs, vaccines, or devices). It mandates that all public health communications - such as educational materials or campaign messaging - must align with FDA-approved claims and avoid unproven statements about benefits. Existing materials that don’t comply must be removed within 30 days, and agencies must implement internal reviews and annual reporting to ensure adherence. Violations could lead to disciplinary action against staff, and corrections must be issued through the same channels as the original non-compliant message. The bill aims to rebuild public trust by ensuring state health communications match federal regulatory standards.
Sub-Topics Public Health
signed · Washington · House Apr 7, 2025

HB 1209: Protecting public health and safety by regulating the transfer of sodium nitrite.

HB 1209 regulates the sale and transfer of sodium nitrite (a chemical used in food preservation and industry) by requiring warning labels on products containing over 10% sodium nitrite and restricting sales to commercial businesses. It mandates that sellers verify a buyer’s commercial need using an employer ID number, banning sales to individuals or non-verified entities. The law requires labels stating "WARNING: Deadly if ingested. Seek immediate medical attention..." to alert users about severe health risks, including methemoglobinemia. The bill, effective April 7, 2025, directly affects retailers, online sellers, and commercial users of sodium nitrite while aiming to reduce suicide-related deaths linked to its misuse.
Sub-Topics Public Health
in committee · Washington · Senate Jan 12, 2026

SB 5183: Prohibiting the sale of certain tobacco and nicotine products.

SB 5183 bans the sale of all flavored tobacco and nicotine products (like fruit or candy-flavored cigarettes, cigars, or e-cigarettes) and vapor products with interactive gaming features (e.g., Pac-Man displays) in Washington starting January 1, 2026. It directly affects retailers who sell these products, including those marketing to youth with appealing flavors and games. The bill defines "flavored" broadly to include any taste, smell, or cooling sensation beyond tobacco, and "entertainment vapor products" as devices with gaming or video features. This policy change aims to reduce youth initiation and addiction by removing products specifically designed to appeal to young people, based on public health data showing flavored products drive most youth tobacco use.
signed · Washington · House Apr 21, 2025

HB 1531: Preserving the ability of public officials to address communicable diseases.

House Bill 1531 establishes a state policy that public health responses to communicable diseases must be guided by the best available science and evidence-based measures, including immunizations and vaccines. It requires state and local health officials to implement and promote these measures within available resources. The bill also prohibits the state or any local government from enacting laws or policies that forbid the implementation and promotion of such measures, declaring any existing prohibitive policies null and void. This legislation clarifies the ability of public health officials to use scientifically proven methods to control disease spread, without creating new requirements for individuals to receive vaccines.
Sub-Topics Public Health
in committee · Washington · Senate Jan 12, 2026

SB 5709: Concerning county property tax levies for public health clinic purposes.

Washington State bill SB 5709 allows counties to levy an additional property tax of up to 5 cents per $1,000 of assessed value annually, specifically for public health clinics. This tax can only fund clinic operations, maintenance, and capital expenses, and is exempt from certain existing property tax limits in state law. The bill defines "public health clinic" broadly to include services like primary care, dental, reproductive health, disease prevention, and behavioral health. It directly affects Washington counties (which may choose to adopt this tax) and public health clinics (which would receive dedicated funding). The bill amends existing tax code sections to explicitly include public health clinic funding as an exception to general tax levy restrictions.
in committee · Washington · House Jan 12, 2026

HB 1034: Concerning nonopioid drugs for the treatment of pain.

HB 1034 requires health insurance plans in Washington to cover nonopioid pain treatments equally with opioid drugs starting January 1, 2026. It prohibits plans from designating nonopioid drugs as "nonpreferred" when opioids are preferred or imposing stricter requirements (like prior authorization) on nonopioid options compared to opioids. The bill also mandates the state to create and publish an educational pamphlet about nonopioid pain treatment alternatives by 2026, detailing available options and their pros and cons. This applies to all health plans, managed care organizations, and public health programs covered under the law. The legislation directly affects insurers and patients by changing coverage rules for pain management.
in committee · Washington · House Jan 12, 2026

HB 1870: Concerning county property tax levies for public health clinic purposes.

HB 1870 allows Washington counties to levy an additional property tax of up to five cents per $1,000 of assessed value specifically for public health clinics. This tax can only fund the operation, maintenance, and capital expenses of clinics providing services like primary care, dental care, disease prevention, reproductive health, and behavioral health. The bill amends existing tax laws to exempt this new levy from standard county tax limits (like the $1.80 cap), ensuring it doesn’t count toward other spending restrictions. It directly affects counties and public health clinics, which would use the funds for low-barrier health services to underserved communities.
in committee · Washington · House Jan 12, 2026

HB 1413: Prohibiting government purchases of opioid overdose reversal medications from certain entities.

HB 1413 prohibits Washington state agencies, counties, cities, and towns from purchasing opioid overdose reversal medications (commonly known as naloxone) from companies that have settled with states over claims of contributing to the opioid epidemic. The bill requires the Department of Health to maintain a public list of excluded entities and exempts companies already supplying these medications under pre-existing settlement agreements as of September 1, 2024. It directly affects government purchasers of naloxone by restricting their vendor options to distributors not linked to opioid settlement cases. The law aims to redirect procurement toward qualified distributors with no prior involvement in the opioid crisis.
Showing 11 to 19 of 19 bills